Breaking News Instant updates and real-time market news.

Q

QuintilesIMS

$76.83

-4.1 (-5.07%)

05:59
12/01/16
12/01
05:59
12/01/16
05:59

QuintilesIMS downgraded to Market Perform from Outperform at William Blair

Q QuintilesIMS
$76.83

-4.1 (-5.07%)

10/27/16
PIPR
10/27/16
DOWNGRADE
Target $72
PIPR
Neutral
Quintiles downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Sean Wieland downgraded Quintiles to Neutral saying risks from the merger with IMS are not priced in. Consolidation of data suppliers may increase data acquisition costs in 2018, Wieland tells investors in a research note. Further, he believes the business of clinical trial recruitment will get more challenging. The analyst lowered his price target for Quintiles to $72 from $75.
11/30/16
LEHM
11/30/16
INITIATION
Target $90
LEHM
Overweight
QuintilesIMS reinstated with an Overweight at Barclays
Barclays analyst Douglas Tsao reinstated QuintilesIMS with an Overweight and a $90 price target.
12/01/16
12/01/16
DOWNGRADE

Market Perform
QuintilesIMS downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst Michael Baker downgraded QuintilesIMS to Market Perform from Strong Buy citing product development challenges and integration risks. The analyst said QuintilesIMS Product Development as-contracted book-to-bill was "underwhelming" at .95x for Q3 and soft new business awards, the loss of Takeda to PRA Health Sciences, and recent cancellations will impact results over the next few quarters. Further, the combination of the central labs and the CRO will likely take longer than expected, the analyst wrote.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.